Sign Up
OverviewAPI
The global biopharmaceutical fermentation market is projected to reach USD 24.82 billion in 2022 and is expected to grow at a CAGR of 8.15% through 2028. The market is driven by factors such as the increasing demand for biotech-based drugs, rising research and development activities, and the need for consistent product quality. North America leads the market growth due to the dominance of downstream products and the expanding biosimilars market, while high costs of biopharmaceutical fermentation and installation are expected to hinder market growth.

Ask a question